Stage II Rectal Cancer

12 clinical trials · Condition

Record	Firm	Date
Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab (NCT04164069)	Anne Noonan	2020-09-02
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190)	Stanford University	2017-08-08
Randomizing Two Radiotherapy Boost Options to Avoid Rectal Cancer Surgery (NCT03051464)	Sir Mortimer B. Davis - Jewish General Hospital	2017-04-25
Low Glycemic Load Diet in Patients With Stage I-III Colon Cancer (NCT02129218)	Case Comprehensive Cancer Center	2015-02-16
Laparoscopic Surgery or Robotic-Assisted Laparoscopic Surgery in Treating Patients With Rectal Cancer That Can Be Removed By Surgery (NCT01196000)	City of Hope Medical Center	2011-12-01
Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma (NCT01302613)	University of Texas Southwestern Medical Center	2011-03-01
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery (NCT00433576)	National Cancer Institute (NCI)	2006-12-01
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer (NCT00303628)	ECOG-ACRIN Cancer Research Group	2006-05-11
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer (NCT00087191)	National Cancer Institute (NCI)	2004-05-01
Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer (NCT00052559)	National Cancer Institute (NCI)	2002-08-01
Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Followed by Surgery in Treating Patients With Locally Advanced Cancer of the Rectum (NCT00006094)	National Cancer Institute (NCI)	2000-07-01

Track Stage II Rectal Cancer automatically

Every clearance here is in the API, with alerts when new ones post.